Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1110-05 Phase IIa trial in fibromyalgia
jRCT2031240522Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing ONO-1110 once daily with Placebo once daily (2 arms). Primary endpoints: Change in weekly mean of average pain score and Safety endpoints. Started Mar 2025; status: completed.
02
Drugs
ONO-1110
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on jRCT2031240522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240522.